These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

191 related articles for article (PubMed ID: 30420183)

  • 1. Meta-analysis Comparing Culprit Vessel Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction and Cardiogenic Shock.
    Khan MS; Siddiqi TJ; Usman MS; Riaz H; Khan AR; Murad MH; Kalra A; Figueredo VM; Bhatt DL
    Am J Cardiol; 2019 Jan; 123(2):218-226. PubMed ID: 30420183
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Outcomes of multivessel vs culprit lesion-only percutaneous coronary intervention in patients with acute myocardial infarction complicated by cardiogenic shock: Evidence from an updated meta-analysis.
    Kundu A; Sardar P; Kakouros N; Malhotra R; Kolte D; Feldman DN; Abbott JD; Fisher DZ
    Catheter Cardiovasc Interv; 2019 Jul; 94(1):70-81. PubMed ID: 30593731
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Culprit Vessel Only Versus Multivessel Percutaneous Coronary Intervention in Acute Myocardial Infarction with Cardiogenic Shock: A Systematic Review and Meta-Analysis.
    Khalid MF; Khan AA; Khattak F; Ayub MT; Bagai J; Mukherjee D; Helton T; Cohen MG; Banerjee S; Paul TK
    Cardiovasc Revasc Med; 2019 Nov; 20(11):956-964. PubMed ID: 30638891
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Culprit Vessel-Only Versus Multivessel Percutaneous Coronary Intervention in Patients With Cardiogenic Shock Complicating ST-Segment-Elevation Myocardial Infarction: A Collaborative Meta-Analysis.
    Kolte D; Sardar P; Khera S; Zeymer U; Thiele H; Hochadel M; Radovanovic D; Erne P; Hambraeus K; James S; Claessen BE; Henriques JPS; Mylotte D; Garot P; Aronow WS; Owan T; Jain D; Panza JA; Frishman WH; Fonarow GC; Bhatt DL; Aronow HD; Abbott JD
    Circ Cardiovasc Interv; 2017 Nov; 10(11):. PubMed ID: 29146672
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Multivessel versus culprit lesion only percutaneous coronary intervention in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.
    de Waha S; Jobs A; Eitel I; Pöss J; Stiermaier T; Meyer-Saraei R; Fuernau G; Zeymer U; Desch S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2018 Feb; 7(1):28-37. PubMed ID: 28703046
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Culprit Vessel Versus Multivessel Versus In-Hospital Staged Intervention for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease: Stratified Analyses in High-Risk Patient Groups and Anatomic Subsets of Nonculprit Disease.
    Iqbal MB; Nadra IJ; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Della Siega A; Robinson SD;
    JACC Cardiovasc Interv; 2017 Jan; 10(1):11-23. PubMed ID: 28057282
    [TBL] [Abstract][Full Text] [Related]  

  • 7. PCI Strategies in Patients with Acute Myocardial Infarction and Cardiogenic Shock.
    Thiele H; Akin I; Sandri M; Fuernau G; de Waha S; Meyer-Saraei R; Nordbeck P; Geisler T; Landmesser U; Skurk C; Fach A; Lapp H; Piek JJ; Noc M; Goslar T; Felix SB; Maier LS; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Barthelemy O; Huber K; Windecker S; Savonitto S; Torremante P; Vrints C; Schneider S; Desch S; Zeymer U;
    N Engl J Med; 2017 Dec; 377(25):2419-2432. PubMed ID: 29083953
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Culprit-Only Versus Immediate Multivessel Percutaneous Coronary Intervention in Patients With Acute Myocardial Infarction Complicating Advanced Cardiogenic Shock Requiring Venoarterial-Extracorporeal Membrane Oxygenation.
    Choi KH; Yang JH; Park TK; Lee JM; Song YB; Hahn JY; Choi SH; Ahn CM; Yu CW; Park IH; Jang WJ; Kim HJ; Bae JW; Kwon SU; Lee HJ; Lee WS; Jeong JO; Park SD; Kang TS; Gwon HC
    J Am Heart Assoc; 2023 May; 12(10):e029792. PubMed ID: 37158104
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Multivessel vs. culprit-vessel only percutaneous coronary interventions in acute myocardial infarction and cardiogenic shock: a systematic review and meta-analysis of prospective randomized and retrospective studies.
    Gill GS; Sánchez JS; Thandra A; Kanmanthareddy A; Alla VM; Garcia-Garcia HM
    Eur Heart J Acute Cardiovasc Care; 2022 Jul; 11(7):558-569. PubMed ID: 35680428
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The prognostic impact of revascularization strategy in acute myocardial infarction and cardiogenic shock: Insights from the British Columbia Cardiac Registry.
    McNeice A; Nadra IJ; Robinson SD; Fretz E; Ding L; Fung A; Aymong E; Chan AW; Hodge S; Webb J; Sheth T; Jolly SS; Mehta SR; Della Siega A; Wood DA; Iqbal MB;
    Catheter Cardiovasc Interv; 2018 Nov; 92(5):E356-E367. PubMed ID: 29698573
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Sex-Specific Management in Patients With Acute Myocardial Infarction and Cardiogenic Shock: A Substudy of the CULPRIT-SHOCK Trial.
    Rubini Gimenez M; Zeymer U; Desch S; de Waha-Thiele S; Ouarrak T; Poess J; Meyer-Saraei R; Schneider S; Fuernau G; Stepinska J; Huber K; Windecker S; Montalescot G; Savonitto S; Jeger RV; Thiele H
    Circ Cardiovasc Interv; 2020 Mar; 13(3):e008537. PubMed ID: 32151161
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Revascularization strategies in cardiogenic shock complicating acute myocardial infarction: A systematic review and meta-analysis.
    Rahman H; Khan SU; Lone AN; Kaluski E
    Cardiovasc Revasc Med; 2018 Sep; 19(6):647-654. PubMed ID: 29909948
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Immediate multivessel intervention versus culprit-vessel intervention only in patients with ST-elevation myocardial infarction and multivessel coronary disease: data from the prospective KAMIR-NIH registry.
    Ahn SG; Lee JW; Kang DR; Kim HS; Go TH; Yu MH; Kim JH; Jung MH; Park JS; Chae SC; Cho MC; Kim CJ; Gwon HC; Kim HS; Seung KB; Cha KS; Chae JK; Joo SJ; Rha SW; Choi DJ; Hur SH; Seong IW; Kim DI; Oh SK; Ahn TH; Hwang JY; Yoon J;
    Coron Artery Dis; 2019 Mar; 30(2):95-102. PubMed ID: 30707685
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Current clinical management of acute myocardial infarction complicated by cardiogenic shock.
    El Nasasra A; Zeymer U
    Expert Rev Cardiovasc Ther; 2021 Jan; 19(1):41-46. PubMed ID: 33289436
    [TBL] [Abstract][Full Text] [Related]  

  • 15. One-Year Outcomes after PCI Strategies in Cardiogenic Shock.
    Thiele H; Akin I; Sandri M; de Waha-Thiele S; Meyer-Saraei R; Fuernau G; Eitel I; Nordbeck P; Geisler T; Landmesser U; Skurk C; Fach A; Jobs A; Lapp H; Piek JJ; Noc M; Goslar T; Felix SB; Maier LS; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Barthelemy O; Huber K; Windecker S; Hunziker L; Savonitto S; Torremante P; Vrints C; Schneider S; Zeymer U; Desch S;
    N Engl J Med; 2018 Nov; 379(18):1699-1710. PubMed ID: 30145971
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Editor's Choice- Impact of immediate multivessel percutaneous coronary intervention versus culprit lesion intervention on 1-year outcome in patients with acute myocardial infarction complicated by cardiogenic shock: Results of the randomised IABP-SHOCK II trial.
    Zeymer U; Werdan K; Schuler G; Zahn R; Neumann FJ; Fürnau G; de Waha S; Schneider S; Thiele H
    Eur Heart J Acute Cardiovasc Care; 2017 Oct; 6(7):601-609. PubMed ID: 27655918
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Multivessel Versus Culprit-Vessel Percutaneous Coronary Intervention in Cardiogenic Shock.
    Lemor A; Basir MB; Patel K; Kolski B; Kaki A; Kapur NK; Riley R; Finley J; Goldsweig A; Aronow HD; Belford PM; Tehrani B; Truesdell AG; Lasorda D; Bharadwaj A; Hanson I; LaLonde T; Gorgis S; O'Neill W;
    JACC Cardiovasc Interv; 2020 May; 13(10):1171-1178. PubMed ID: 32360256
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Meta-Analysis of Randomized Controlled Trials Comparing Multivessel Versus Culprit-Only Revascularization for Patients With ST-Segment Elevation Myocardial Infarction and Multivessel Disease Undergoing Primary Percutaneous Coronary Intervention.
    El-Hayek GE; Gershlick AH; Hong MK; Casso Dominguez A; Banning A; Afshar AE; Herzog E; Tamis-Holland JE
    Am J Cardiol; 2015 Jun; 115(11):1481-6. PubMed ID: 25840579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognostic Value of SYNTAX Score in Patients With Infarct-Related Cardiogenic Shock: Insights From the CULPRIT-SHOCK Trial.
    Guedeney P; Barthélémy O; Zeitouni M; Hauguel-Moreau M; Hage G; Kerneis M; Lattuca B; Overtchouk P; Rouanet S; Fuernau G; de Waha-Thiele S; Zeymer U; Sandri M; Akin I; Desch S; Thiele H; Montalescot G
    JACC Cardiovasc Interv; 2020 May; 13(10):1198-1206. PubMed ID: 32438990
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Multivessel versus culprit lesion only percutaneous revascularization plus potential staged revascularization in patients with acute myocardial infarction complicated by cardiogenic shock: Design and rationale of CULPRIT-SHOCK trial.
    Thiele H; Desch S; Piek JJ; Stepinska J; Oldroyd K; Serpytis P; Montalescot G; Noc M; Huber K; Fuernau G; de Waha S; Meyer-Saraei R; Schneider S; Windecker S; Savonitto S; Briggs A; Torremante P; Vrints C; Schuler G; Ceglarek U; Thiery J; Zeymer U;
    Am Heart J; 2016 Feb; 172():160-9. PubMed ID: 26856228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.